企業プロフィール
Omeros 株価・ニュース・カタリスト
- ティッカー:
- OMER
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
19.32 USD (+0.26%)
終値
最終更新: 2026年8月24日
743M USD
時価総額
株価変動の要因
As of Aug 24, 2026, OMER closed up 0.26% at $19.32. No new same-company headline was identified in the current news window.
企業概要
事業概要
Omeros is a biotechnology company with programs in immunology, complement biology, and rare disease. The company has long been defined by a mix of scientific ambition and a complicated commercial path.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Omeros sits in specialty biotechnology.
ビジネスモデルの特徴
The business depends on clinical validation, portfolio management, and the ability to unlock value from a narrow set of programs.
バイオ業界での位置付け
Omeros is a high-uncertainty biotech name whose valuation is driven by pipeline outcomes and strategic progress.
今後のカタリスト
- Omeros’s catalysts are narsoplimab and the remaining complement / immunology assets. Investors will focus on whether the company can still turn its late-stage biology into something commercially relevant.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。